TSS
TEVA icon

Two Sigma Securities’s Teva Pharmaceuticals TEVA Stock Holding History

Two Sigma Securities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-26,200
Closed -$472K – 3130
2024
Q3 		$472K Sell
26,200
-98,500
-79% -$1.72M 0.01% 1370
2024
Q2 		$2.03M Sell
124,700
-137,300
-52% -$2.11M 0.02% 709
2024
Q1 		$3.7M Buy
262,000
+221,600
+549% +$2.79M 0.04% 495
2023
Q4 		$422K Buy
+40,400
New +$377K ﹤0.01% 1681
2023
Q1 		– Sell
-64,200
Closed -$586K – 3258
2022
Q4 		$586K Buy
64,200
+54,000
+529% +$471K 0.02% 981
2022
Q3 		$82K Buy
+10,200
New +$90.2K ﹤0.01% 2123
2022
Q1 		– Sell
-16,700
Closed -$134K – 2501
2021
Q4 		$134K Buy
+16,700
New +$151K 0.01% 1138
2021
Q3 		– Sell
-11,300
Closed -$112K – 1955
2021
Q2 		$112K Buy
11,300
+100
+0.9% +$1.06K ﹤0.01% 1351
2021
Q1 		$129K Sell
11,200
-13,700
-55% -$157K 0.01% 679
2020
Q4 		$240K Buy
24,900
+9,700
+64% +$92.9K 0.01% 1235
2020
Q3 		$137K Buy
+15,200
New +$161K ﹤0.01% 1159
2020
Q2 		– Sell
-47,500
Closed -$427K – 1732
2020
Q1 		$427K Buy
+47,500
New +$487K 0.01% 688
2019
Q3 		– Sell
-41,500
Closed -$383K – 2452
2019
Q2 		$383K Sell
41,500
-104,600
-72% -$1.26M ﹤0.01% 1299
2019
Q1 		$2.29M Buy
146,100
+86,300
+144% +$1.52M 0.02% 298
2018
Q4 		$922K Sell
59,800
-110,700
-65% -$2.27M 0.01% 673
2018
Q3 		$3.67M Sell
170,500
-181,600
-52% -$4.22M 0.02% 477
2018
Q2 		$8.56M Buy
352,100
+12,400
+4% +$253K 0.04% 320
2018
Q1 		$5.8M Buy
339,700
+286,600
+540% +$5.6M 0.03% 431
2017
Q4 		$1.01M Buy
+53,100
New +$799K 0.03% 421

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Two Sigma Securities's TEVA Position: Q3 2024 in Review

Two Sigma Securities sold out of Teva Pharmaceuticals (TEVA) in Q3 2024, closing a stake of 16,253 shares — an estimated $284K sold.

Two Sigma Securities first reported a position in TEVA in Q1 2016 and held it in 25 quarters. The position peaked at $2.54M in Q3 2016. 542 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • Two Sigma Securities reported no remaining Teva Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Securities sold 16,253 Teva Pharmaceuticals shares in Q3 2024, an estimated $284K.
  • Two Sigma Securities first reported a position in Teva Pharmaceuticals in Q1 2016 and held it in 25 quarters.
  • Two Sigma Securities's Teva Pharmaceuticals position peaked at $2.54M in Q3 2016.
  • 542 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.